Filings For: Telomir Pharmaceuticals, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Telomir Pharmaceuticals, Inc. (TELO) 11/6/2026 4:55:48 PM Micro View Financials 10-Q SEC 3Q 2026 ending: 9/30/2026 Assets $4,641,345 EPS -$0.01
Telomir Pharmaceuticals, Inc. (TELO) 8/13/2026 5:23:41 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $5,365,904 EPS -$0.79
Telomir Pharmaceuticals, Inc. (TELO) 7/28/2026 5:00:28 PM   View Proxy SEC Y 2025
Telomir Pharmaceuticals, Inc. (TELO) 5/14/2026 3:25:51 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $5,789,536 EPS -$0.03
Telomir Pharmaceuticals, Inc. (TELO) 3/17/2026 5:32:04 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $7,341,361 EPS -$0.33
Telomir Pharmaceuticals, Inc. (TELO) 2/19/2026 5:17:46 PM   View Proxy SEC Y 2025
Telomir Pharmaceuticals, Inc. (TELO) 11/10/2025 4:13:34 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $7,402,117 EPS -$0.03
Telomir Pharmaceuticals, Inc. (TELO) 8/14/2025 4:14:59 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $829,611 EPS $0.17
Telomir Pharmaceuticals, Inc. (TELO) 5/14/2025 4:43:48 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $491,188 EPS -$0.07
Telomir Pharmaceuticals, Inc. (TELO) 2/4/2025 4:52:23 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Assets $1,324,005 EPS $0.56
Telomir Pharmaceuticals, Inc. (TELO) 11/12/2024 4:23:47 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024
Telomir Pharmaceuticals, Inc. (TELO) 8/13/2024 4:19:23 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024
Telomir Pharmaceuticals, Inc. (TELO) 5/13/2024 4:49:05 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024
Telomir Pharmaceuticals, Inc. (TELO) 3/29/2024 5:37:48 PM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023